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Many Stramenopile species belonging to oomycetes from the genus Saprolegnia infect 
fish, amphibians, and crustaceans in aquaculture farms and natural ecosystems. 
Saprolegnia parasitica is one of the most severe fish pathogens, responsible for high 
losses in the aquaculture industry worldwide. Most of the molecules reported to date for 
the control of Saprolegnia infections either are inefficient or have negative impacts on the 
health of the fish hosts or the environment resulting in substantial economic losses. Until 
now, the whole proteome of S. parasitica has not been explored for a systematic screening 
of novel inhibitors against the pathogen. The present study was designed to develop a 
consensus computational framework for the identification of potential target proteins and 
their inhibitors and subsequent experimental validation of selected compounds. 
Comparative analysis between the proteomes of Saprolegnia, humans and fish species 
identified proteins that are specific and essential for the survival of the pathogen. The 
DrugBank database was exploited to select food and drug administration (FDA)-approved 
inhibitors whose high binding affinity to their respective protein targets was confirmed by 
computational modeling. At least six of the identified compounds significantly inhibited 
the growth of S. parasitica in vitro. Triclosan was found to be most effective with a minimum 
inhibitory concentration (MIC100) of 4 μg/ml. Optical microscopy showed that the inhibitors 
affect the morphology of hyphal cells, with hyper-branching being commonly observed. 
The inhibitory effects of the compounds identified in this study on Saprolegnia’s mycelial 
growth indicate that they are potentially usable for disease control against this class of 
oomycete pathogens. Similar approaches can be easily adopted for the identification of 
potential inhibitors against other plant and animal pathogenic oomycete infections.
Keywords: disease control, fish pathogen, growth inhibitors, oomycete, Saprolegnia parasitica, in silico  
proteomics
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INTRODUCTION
Most species from the oomycete genus Saprolegnia are 
opportunistic parasites (Plumb, 1999) that cause the disease 
saprolegniasis in various fish species (van West, 2006), 
amphibians (Blaustein et  al., 1994), crustaceans (Diéguez-
Uribeondo et al., 1994), and other aquatic animals (Fernandez-
Beneitez et  al., 2011). The virulent strains of Saprolegnia 
parasitica infect eggs, juvenile, and adult fish, leading to 
important losses in fish farms worldwide (van West, 2006). 
The chemical malachite green was used effectively for the 
treatment of saprolegniasis (Willoughby and Roberts, 1992) 
until it was banned in 2002 by the United  States and several 
other countries due to its carcinogenic and mutagenic effects 
in humans and animals (Srivastava et al., 2004). The aquaculture 
production is increasing every year, and due to the lack of 
suitable and effective chemicals to control saprolegniasis, a 
re-emergence and spread of the disease is observed worldwide. 
Losses due to S. parasitica are higher in fish farms than in 
wild environments because the farmed animals are typically 
held in high densities and exposed to constant stress and 
various types of pollutants, factors that altogether increase 
the risk of infection and spread of the disease.
To date, multiple chemicals have been trialed to control 
saprolegniasis (Table  1), but their negative impact on the 
environment or the health of fish farmers or the fish hosts 
typically prevents their practical use in aquaculture. Two main 
classes of molecules have been investigated that have either 
general antimicrobial activity or a more targeted mode of 
action. From the first class, the least harmful compound is 
sodium chloride, but this salt is efficient only at high 
concentrations, which makes its use impractical in freshwater 
(Das et al., 2012). Hydrogen peroxide also has minimal impact 
on the environment and has been used to efficiently treat 
Saprolegnia infections in catfish (Howe et  al., 1999). More 
recently, however, its application has been shown to provoke 
negative side effects, such as reduced fish growth and damage 
to the gills (Mustafa, 2019). Likewise, while boric acid inhibits 
germination and colonization of spores as well as mycelial 
growth in Saprolegnia species (Ali et  al., 2014), an excess of 
boron affects DNA integrity of blood and sperm cells in Nile 
tilapia (Acar et  al., 2018) and adversely impacts the growth 
of rainbow trout (Öz et  al., 2018). Peracetic acid is another 
nonspecific antimicrobial chemical with proven activity against 
S. parasitica (Marchand et  al., 2012), but its use in fish farms 
is hindered by the fact that it causes lacrimation at low 
concentrations as well as extreme discomfort and irritation of 
the upper respiratory tract in humans (N. R. Council, 2010). 
Other efficient compounds have adverse effects on the 
environment. Examples are formaldehyde, sometimes used for 
the treatment of eggs and larval stages (Gieseker et  al., 2006), 
and copper sulfate, which inhibits Saprolegnia growth by affecting 
multiple biological functions, including protein and energy 
biogenesis (Hu et  al., 2016).
Other chemicals with more specific modes of action have 
been tested against Saprolegnia species. For example, bronopol 
(2-bromo-2-nitropropane-1,3-diol) and its methyl derivative 
2-methyl-4-isothiazolin-3-one oxidize thiol groups in proteins and 
are, as such, inhibitors of dehydrogenases. These chemicals have 
been identified as promising compounds for the control of 
Saprolegnia infections in ova and adult fish (Branson, 2002; Oono 
and Hatai, 2007), although tolerant strains of Saprolegnia have 
been reported (Rezinciuc et  al., 2014). Further chemicals of the 
oxyalkylchalcone class have been developed to overcome bronopol 
resistance. Promising molecules with higher inhibitory activity 
than bronopol on Saprolegnia growth are 2',4'-dihydroxychalcone 
and its oxyalkylated derivative produced by chemical synthesis, 
2-hydroxy, 4-farnesyloxychalcone (Flores et al., 2016). However, 
these molecules were tested in vitro only and there are no 
results that demonstrate both their efficiency in infected animals 
and innocuousness to the environment. An attractive alternative 
approach to the chemical synthesis of novel inhibitors is the 
search for natural molecules that exhibit antimicrobial 
properties. Relevant examples that have been shown to 
be  effective against S. parasitica with weak or no activity 
against fungi, bacteria, microalgae, or zooplankton are the 
angucycline antibiotics saprolmycins A and E from Streptomyces 
sp. (Nakagawa et al., 2012). Likewise, cladomarine and quellenin, 
two antibiotics produced by the deep-sea fungus Penicillium 
coralligerum (YK-247) and Aspergillus sp. (strain YK-76), 
respectively, were shown to exhibit anti-Saprolegnia activity 
(Takahashi et  al., 2017). However, despite the discovery of 
these promising natural anti-oomycete compounds, their large-
scale production has proven to be challenging and too expensive 
to be  commercially viable.
Despite the numerous efforts mentioned above, we are still 
lacking compounds that can be  used in the aquaculture 
industry to tackle saprolegniasis. Bioinformatic approaches 
have allowed the identification of inhibitors of bacterial 
pathogens of humans (Solanki and Tiwari, 2018; Bhardwaj 
et  al., 2019; Cesur et  al., 2020). Inspired by these successful 
strategies, here, we  aim to identify specific protein targets 
and potential lead inhibitors of S. parasitica using combined 
in silico subtractive proteomics with a sequence-based approach. 
Our strategy presented in Figure  1 consisted in the analysis 
of the whole predicted proteome of S. parasitica and its 
comparison with fish and human proteomes to identify 
non-homologous essential proteins from the pathogen. The 
DrugBank database was subsequently searched to select potential 
food and drug administration (FDA)-approved inhibitors of 
these proteins, which were subsequently tested in vitro for 
their efficacy in arresting the growth of S. parasitica. With 
this approach, we have identified several inhibitors that exhibit 
MIC100 as low as 4 μg/ml. Their interactions with their protein 
targets were also studied by computational modeling, providing 
further evidence of the specific nature of the observed inhibitory 
effects. Similar strategy to identify and test novel compounds 
can be  extended to other pathogenic oomycetes.
Abbreviations: CDD, Conserved domain database; DDAC, Didecyldimethylammonium 
chloride; DEG, Database of essential genes; DHFR, Dihydrofolate reductase; DHPS, 
Dihydropteroate synthase; DMSO, Dimethyl sulfoxide; FDA, Food and drug 
administration; PDA, Potato dextrose agar; SDR, Short-chain dehydrogenases/
reductases.
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MATERIALS AND METHODS
Identification of Non-homologous 
Essential Proteins
The predicted proteome of S. parasitica (strain CBS 223.65) was 
retrieved from the NCBI website1 using genome assembly 
ASM15154v2. Conserved protein domains were predicted using 
pfam v31.0 (Finn et  al., 2016) and conserved domain database 
(CDD; Marchler-Bauer et  al., 2017). Protein sequences deduced 
from the human (Homo sapiens GRCh38.p11) and 15 fish 
genomes (Supplementary Table S1) were compared with the 
1 www.ncbi.nlm.nih.gov/genome
sequences from S. parasitica using blastp (BLAST 2.2.31+). The 
Saprolegnia proteins that did not present any significant sequence 
similarity (E-value  <  1.0E-03, bitscore  >  100) with any of the 
human or fish proteins were considered as non-homologous 
and used for further analysis. Their sequences were searched 
against the Database of Essential Genes (DEG v15.2; Luo et  al., 
2014) using blastp to create a list of essential proteins from 
S. parasitica. The DEG database comprises genes from archaea, 
bacteria, and eukaryotes that are known to be  vital for the 
organism considered. As it is generally assumed that proteins 
essential to one organism are also likely to be  essential to other 
organisms, proteins from S. parasitica similar to proteins from 
the DEG database, i.e., proteins with an E-value  <  1.0E-05 and 
a bitscore  >  100, were considered as potential targets of 
anti-oomycete compounds and used for further analysis.
Druggability Potential of Non-homologous 
Essential Proteins
An effective way to estimate the druggability of a protein, i.e., 
its capacity to bind one or several inhibitors, is to identify in 
the first instance similar proteins that have been shown to 
interact with these inhibitors (Keller et al., 2006). The DrugBank 
database (v5.1.1; Wishart et  al., 2018) is a unique collection 
of bioinformatic and cheminformatic resources that combines 
drug data with information on the corresponding protein targets. 
The non-homologous essential proteins from S. parasitica 
identified as described above were searched against the DrugBank 
database using blastp. The proteins that showed significant 
scores (E-value < 1.0E-05, bitscore > 100) and their corresponding 
FDA-approved compounds were further considered.
Homology Modeling and Docking
Homology modeling was performed using the CPHmodels 3.2 
Server (Nielsen et  al., 2010) that uses profile-profile alignment 
guided by protein secondary structure and exposure predictions 
for template identification. The generated models were further 
FIGURE 1 | Schematic representation of the subtractive proteomics 
approach used in the present study. The whole proteome of Saprolegnia 
parasitica was searched using blastp (E-value < 1.0E-03, bitscore > 100) 
against human and fish proteomes followed by Database of Essential Genes 
(DEG) and finally, against DrugBank database for identification of food and 
drug administration (FDA)-approved inhibitor compounds.
TABLE 1 | List of compounds reported earlier to be effective in controlling the growth and spread of S. parasitica in aquaculture.
Drugs Effective concentration Target/Mechanism References
NaCl ~15 mg/ml Unknown Marking et al., 1994; Das et al., 2012
Formalin 0.1 mg/ml Unknown Gieseker et al., 2006; Khodabandeh and Abtahi, 2006
Boric acid 0.5 mg/ml Germination and colonization Ali et al., 2014
Peracetic acid 4–10 μg/ml Unknown Marchand et al., 2012
Hydrogen peroxide 50–250 μg/ml Unknown Mitchell and Collins, 1997
Clotrimazole ~1–2 μg/ml CYP51 sterol 14α-demethylase Warrilow et al., 2014
Copper sulfate 0.5 μg/ml Protein and energy biogenesis Sun et al., 2014
Bronopol 30 μg/ml Dehydrogenase inhibitor Pottinger and Day, 1999; Branson, 2002
Saprolmycins A–E 
angucycline antibiotic
3.9–7.8 ng/ml Unknown, probably histidine kinases inhibitor Nakagawa et al., 2012
Chitosans ~0.4 mg/ml Fungicidal Muzzarelli et al., 2001
Oridamycins 3.0 μg/ml Unknown Takada et al., 2010
Dioscin 2.0 μg/ml
Damages mycelium, accumulation of reactive 
oxygen species
Liu et al., 2015
Amphotericin B 5.0 μg/ml Sterol biosynthesis Bly et al., 1996
Cladomarine/Cladosporin 13–23 μg/ml Probable lysyl-tRNA synthetase inhibitor Takahashi et al., 2017
Malachite green 1.0 μg/ml Affects multiple proteins Martin, 1968; Willoughby and Roberts, 1992
Nikkomycin Z 25–99 μg/ml Chitin synthases inhibitor Guerriero et al., 2010
Benzoic acid 100 μg/ml Unknown Tedesco et al., 2019
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minimized using Steepest Descent and the conjugate gradient 
method in Discovery Studio 2.5 (Biovia, 2018). The models 
were used for molecular docking with selected lead compounds 
using AutoDock Vina (Trott and Olson, 2010) in PyRx (Dallakyan, 
2008) with default parameters. The 3D structures of the active 
compounds were retrieved from the DrugBank database and 
minimized in PyRx before docking. The docked complexes 
were further visualized using PyMol (Seeliger and de Groot, 
2010) and LigPlot+ (Laskowski and Swindells, 2011), and the 
corresponding binding energies were calculated using AutoDock 
Vina (Trott and Olson, 2010).
Saprolegnia Cultures and Test of Growth 
Inhibitors
S. parasitica (strain CBS223.65) was maintained on potato 
dextrose agar (PDA) by inoculating Petri dishes with agar 
plugs carrying pre-grown mycelium. The cultures were kept 
at 24°C in the dark, and inoculations were repeated every 
15  days. Growth inhibition experiments were conducted in 
the synthetic medium of Machlis (1953). First, sesame seeds 
carrying S. parasitica mycelium were prepared by spreading 
autoclave-sterilized seeds (121°C for 20  min) on PDA plates 
that contained a central agar plug covered with mycelium. 
After 5  days at 24°C, the seeds coated with hyphal cells were 
transferred to 24-well flat-bottom tissue culture plates (one 
seed per well) containing 1  ml Machlis medium in each well. 
Dilutions of the selected compounds were used to determine 
the effective concentration of each inhibitor (Table  2). Copper 
sulfate (Sun et  al., 2014), boric acid (Ali et  al., 2014), benzoic 
acid (Tedesco et al., 2019), and malachite green (Martin, 1968), 
all known to be  effective inhibitors of S. parasitica, were used 
as positive controls. Solvents of each class of inhibitor, i.e., 
sterile water, dimethyl sulfoxide (DMSO), ethanol, and acetone, 
were used as negative controls. Varying concentrations of each 
solvent (0.01, 0.1, 1.0, and 10.0%) were also tested to determine 
whether they had any effect on the growth of the mycelium 
(Supplementary Figures S1A,B). All concentrations were tested 
in three or more replicates. The plates were incubated at 24°C 
for 4  days, and the extent of mycelial growth in each well 
was observed and measured daily (colony diameter). MIC100 
were defined as the inhibitor concentrations for which no 
growth was observed in four independent replicates after 4 days 
of incubation at 24°C.
Additional growth inhibition experiments were conducted 
on PDA plates. These were prepared using the MIC100 
determined in the Machlis medium and the same positive 
and negative controls as listed above (Supplementary Figure S2). 
Mycelial growth was quantified by measuring the diameter 
of the colonies on the PDA plates pre-inoculated with single 
agar plugs (5 mm) placed at the center of the plates. Experiments 
were conducted in triplicates and measurements of colony 
TABLE 2 | In-vitro screening of the selected compounds on the growth of S. parasitica hyphal cells.
Compounds Solvent MIC range (μg/ml) MIC in Machlis 
medium (μg/ml)
MIC in PDA 
plates (μg/ml)
Microscopy (μg/ml) SPRG targets References
Triclosan Acetone 4–6 6 4 4 SPRG_20215 This study
Acetohydroxamic 
acid
Water 600–800 800 600 600 SPRG_06801
This study
Sulfamethoxazole DMSO 800 800 800 400 SPRG_19504 This study
Chloramphenicol Ethanol 800 800 800 800 SPRG_35021 This study
Azelaic acid Water 800 800 800 800 SPRG_13682 This study
Benzoic acid Water 400–600 600 400 400 SPRG_02663
This study, (Tedesco 
et al., 2019)
Glycerol Water >1,000 ND ND ND SPRG_01876 This study
Albendazole DMSO >1,000 ND ND ND SPRG_07119 This study
Thiabendazole DMSO >1,000 ND ND ND SPRG_07119 This study
Copper sulfate Water 400 400 400 200 Control (Sun et al., 2014)
Boric acid Water 400 400 400 400 Control (Ali et al., 2014)
Malachite green Water 0.8–1.0 1 0.8 0.8 Control (Martin, 1968)
ND, not determined.
FIGURE 2 | Relative growth of S. parasitica on potato dextrose agar (PDA) 
plates. Growth of mycelium (measured as diameter in cm) in the presence of 
sub-inhibitory concentrations of the tested compounds after 0 (day 0), 24 
(day 1), 48 (day 2), and 72 h (day 3) of culture at 24°C. Four independent 
replicates were measured for each drug. A Student’s t-test was also 
performed to check significant differences between drug treated samples 
compared to the sample without drug (*p < 0.0001).
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diameters were made at 0 (day 0), 24 (day 1), 48 (day 2), 
and 72  h (day 3) of culture at 24°C (Figure  2).
Optical Microscopy
The effect of the tested compounds on the morphology of 
hyphal cells was observed by optical microscopy in 24-well 
flat-bottom tissue culture plates which contained 1  ml Machlis 
medium and appropriate dilutions of the lead compounds. 
Controls were performed in parallel as indicated above. 
Observations were made using a Leica Microsystems Ltd. 
DFC295 optical microscope, and images were recorded using 
the Leica Application Suite software v4.1.0.
RESULTS AND DISCUSSION
Identification of Non-homologous 
Essential Proteins in S. parasitica and 
in silico Selection of Growth Inhibitors
To identify essential pathogen-specific proteins and potential 
specific growth inhibitors of S. parasitica, the sequences of all 
predicted proteins from the pathogen were compared with 
human and fish protein sequences (Supplementary Table S1). 
Among the 20,121 proteins encoded by the genome of S. 
parasitica, 5,990 were similar to human or fish proteins and 
were therefore disregarded for further analysis (Figure  1). Out 
of the remaining 14,131 non-homologous proteins, 3,012 showed 
significant similarity with essential proteins in the DEG database. 
These proteins were considered essential for S. parasitica and 
used for further analysis (Supplementary Table S2). Out of 
these, 117 were similar to target sequences in the DrugBank 
database, yielding 231 DrugBank unique entries, of which 45 
are FDA approved (Supplementary Table S3). As the DrugBank 
database enlists not only inhibitors for their respective proteins 
but also interacting compounds, six of these 45 entries (DB01987, 
DB03147, DB03247, DB00140, DB09510, and DB09513) were 
unlikely to be  efficient inhibitors. Hence, the list of potential 
inhibitors of growth was narrowed down to 39 compounds 
(Supplementary Table S3). These were further subdivided  into 
two groups: the first group gathers compounds that potentially 
interact with two or more proteins from S. parasitica, whereas 
the second group consists of molecules that are predicted to 
bind one protein only (Supplementary Table S3).
Compounds Interacting With Two or More 
Essential Proteins From S. parasitica 
(Group 1)
This group contains eight compounds that can potentially interact 
with 29 proteins from Saprolegnia (Supplementary Table S3). 
Interestingly, among these molecules, three are semisynthetic 
echinocandin derivatives, namely caspofungin, anidulafungin, and 
micafungin. Echinocandins are well-characterized antifungal agents 
(Gil-Alonso et al., 2015; Perfect, 2017) that inhibit 1,3-β-d-Glucan 
synthases, i.e., the enzymes responsible for the formation of 
the major cell wall β-glucans in fungi. Earlier work from our 
group has shown that 1,3-β-d-glucans are major components 
of the cell wall of S. parasitica and other oomycete species 
(Bulone et al., 1990; Bulone and Fèvre, 1996; Mélida et al., 2013). 
1,3-β-Glucan synthases have no mammalian homologues and are 
therefore ideal targets for antifungal and anti-oomycete inhibitors 
(Perfect, 2017). CDD analysis of the S. parasitica proteome led 
to the identification of at least 10 proteins that belong to the 
glucan synthase family, including SPRG_05460, which was not 
identified in our in silico screening as an echinocandin-binding 
protein. We  did test multiple echinocandins in previous work 
and showed that they do not inhibit the 1,3-β-Glucan synthases 
of Saprolegnia in  vitro and are therefore unlikely to stop the 
growth of this class of micro-organisms (Bulone, 1992). This 
probably reflects different properties between the fungal and 
oomycete enzymes as one would expect given their low level of 
similarity, which our blast results revealed to be  of 29–34%.
Picric acid, citric acid, and artenimol are three other compounds 
from this group of inhibitors. However, their specificity is predicted 
to be  low, essentially because of their general antimicrobial 
activity. Indeed, picric acid has been used as an antiseptic for 
a long time (Tidy, 1915) and is predicted to inhibit at least 
eight proteins from S. parasitica (Supplementary Table S3). The 
same applies to citric acid, which we  have predicted to interact 
with at least four proteins from S. parasitica, including two 
uncharacterized proteins (SPRG_06530, a probable FtsZ protein, 
and SPRG_11850 and a phosphoribosylaminoimidazole 
carboxylase), a tryptophan synthase (SPRG_05079) and a cell 
division protein FtsZ (SPRG_11942). Tryptophan synthase catalyzes 
the final step of the tryptophan biosynthetic pathway. This enzyme 
is absent in mammals, which makes it an attractive target for 
many other pathogens (Shen et  al., 2009). The cell division 
protein FtsZ has been described as a potential drug target in 
various bacterial pathogens (Shen et  al., 2009), and 
phosphoribosylaminoimidazole carboxylase has been proposed 
previously as a target for drug therapy against Candida albicans 
(Donovan et  al., 2001). Despite these observations, the diversity 
of enzymes and non-catalytic proteins to which citric acid 
potentially binds to suggests that its mode of action is not 
specific. Similarly, artenimol (dihydroartemisinin) is predicted 
to interact with at least two different Saprolegnia proteins, namely 
SPRG_00366, a predicted pyridoxal biosynthesis lyase (PdxS), 
and SPRG_09913, a negative regulator of GroEL domains. 
Interestingly, this compound has been shown to be active against 
a range of organisms as diverse as viruses (Efferth et  al., 2008), 
malarial protozoa (Pull et  al., 2019), plant pathogenic fungi 
(Tang et al., 2000), and even certain tumor cells (Jansen et al., 2011) 
but its efficacy against oomycetes has not been reported.
Another compound identified in group one is formic 
acid. It is predicted to interact with at least three chorismate 
binding enzymes, an anthranilate synthase protein 
(SPRG_06062), and two hypothetical proteins (SPRG_12737 
and SPRG_16397). The antimicrobial activity of formic acid 
has been reported on various bacterial and yeast pathogens 
(Plumed-Ferrer and von Wright, 2011; Lastauskiene et  al., 
2014). However, chronic exposure to this molecule has been 
shown to have adverse health effects similar to those observed 
in methanol poisoning, i.e., metabolic acidosis and ocular 
toxicity (Thompson, 1992).
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α-Phosphoribosylpyrophosphoric acid is predicted to interact 
with two proteins of unknown functions and anthranilate 
phosphoribosyltransferase, which is involved in the biosynthesis 
of aromatic amino acids. This compound is a key intermediate 
of the biosynthesis of nucleotides and likely to interfere with 
other vital processes of the fish hosts. This suggests that it 
would not be  suitable for the management of saprolegniasis.
In conclusion, the compounds from this first group of 
inhibitors are expected to lack specificity (e.g., citric acid) or 
to be  inactive against Saprolegnia (e.g., echinocandins), and, 
in some cases, to have adverse health effects on the fish hosts 
or humans (e.g., formic acid). Thus, in order to select more 
specific inhibitors potentially usable against Saprolegnia, we have 
focused the rest of our study on molecules that are predicted 
to bind a single essential protein in the pathogen.
Compounds Interacting With a Single 
Protein From S. parasitica (Group 2)
This group comprises 31 compounds, the majority being 
sulfonamides or “sulfa drugs” (18 molecules). Sulfonamides 
are predicted to interact with the protein SPRG_19504  in S. 
parasitica, which belongs to the dihydropteroate synthase (DHPS) 
family and contains a 7,8-dihydro-6-hydroxymethylpterin-
pyrophosphokinase (HPPK) domain and a pterin-binding 
domain. In several bacteria and lower eukaryotes, HPPK (EC 
2.7.6.3) and DHPS (EC 2.5.1.15) enzymes catalyze sequential 
reactions in the folic acid biosynthetic pathway (Illarionova 
et  al., 2002). Higher eukaryotes obtain folate from dietary 
sources and lack necessary enzymes for folate biosynthesis 
(Matherly, 2001), whereas eubacteria and lower eukaryotes are 
able to synthesize tetrahydrofolate. Thus, the folate pathway 
is an interesting potential target for anti-infective agents. Indeed, 
DHPS is a well-known target of the sulfonamide class of 
antibacterial drugs (Hevener et  al., 2010). CDD analysis of 
the proteome of S. parasitica revealed the presence of two 
additional proteins involved in the last step of the folic acid 
biosynthetic pathway and annotated as dihydrofolate reductase 
(DHFR), i.e., SPRG_10565 and SPRG_17339. These observations 
suggest that sulfonamides are potential effective inhibitors of 
the growth of Saprolegnia.
Quaternary ammonium compounds like cetrimonium and 
didecyldimethylammonium are predicted to interact with 
SPRG_00820, a hypothetical protein that contains a mycolic acid 
cyclopropane synthetase domain. An antimycotic activity was 
reported for cetrimide, in particular, against fungal keratitis caused 
by Fusarium solani, without any negative effect on eye corneal 
tissues (Mahmoud, 2007). Similarly, didecyldimethylammonium 
chloride (DDAC) is able to inactivate photosystem II (PSII) and 
disintegrate marine phytoplankton species (van Slooten et  al., 
2015). It was also found effective against Escherichia coli where 
it induced the formation of blebs in the cell membrane, causing 
leakage of the intracellular compartment and subsequent cell 
death (Yoshimatsu and Hiyama, 2007).
Triclosan and triclocarban are commonly used broad-spectrum 
antibacterial/antifungal agents that block fatty acid biosynthesis 
by inhibiting enoyl-ACP reductase (Dhillon et  al., 2015). 
Both molecules are predicted to interact with the protein 
SPRG_20215  in S. parasitica, an uncharacterized protein that 
is predicted to contain a short-chain dehydrogenase/reductase 
(SDR) domain. Triclosan has been found to be  effective 
against various Gram-negative and Gram-positive bacteria, 
as well as Mycobacteria (Schweizer, 2001) and Plasmodium 
falciparum (Surolia and Surolia, 2001), where it targets 
dihydrofolate reductase (Bilsland et  al., 2018). This inhibitor 
is also active against the parasite Leishmania panamensis with 
no toxicity toward mammalian cells at concentrations as high 
as 200  μg/ml (Otero et  al., 2014).
The benzimidazoles albendazole and thiabendazole are 
predicted to interact with the protein SPRG_07119 which carries 
a FAD-binding domain and is structurally similar to fumarate 
reductase 2 (PDB 5GLG) from Saccharomyces cerevisiae. 
Benzimidazoles are commonly used as fungicides and 
anthelminthic drugs where they specifically inhibit microtubule 
assembly (Davidse, 1986).
Two other approved compounds from group  2 are 
acetohydroxamic acid (Ohta et  al., 2001) and ecabet (Shibata 
et  al., 1997), which inhibit ureases. In Saprolegnia, both drugs 
are predicted to interact with the protein SPRG_06801, which 
is predicted to be  a nickel-dependent amidohydrolase that 
catalyzes the decomposition of urea into carbamate and ammonia. 
As such, this catabolic reaction represents an important source 
of nitrogen in bacteria, fungi, and plants. Urease activity has 
been reported in Cryptococcus gattii (Feder et  al., 2015) and 
the recently discovered novel systemic fungal pathogen 
Emergomyces africanus (Lerm et al., 2017). Urease is considered 
an essential enzyme and is explored as a target for the 
development of novel antibacterial agents (Follmer, 2010). Our 
in silico proteome analysis suggests that S. parasitica contains 
urease and therefore that inhibitors of this enzyme are worth 
testing against the pathogen.
Azelaic acid is predicted to interact with SPRG_13682, a 
hypothetical protein with 5'-3' exonuclease activity, and an 
N-terminal resolvase-like domain. Azelaic acid has been found 
effective against various Gram-positive and Gram-negative 
bacterial pathogens by inhibiting several oxidoreductases and 
interfering with glycolysis (Nazzaro-Porro, 1987).
Chloramphenicol was also identified in group  2. It is a 
common antibacterial agent that acts by inhibiting protein 
synthesis (Xaplanteri et  al., 2003) and is considered fungistatic 
(Rooke and Shattock, 1983). It has been reported to exert 
variable inhibitory activity on the growth of Phytophthora 
species (Panek and Tomsovsky, 2017). Indeed, resistant strains 
of Phytophthora have been reported (Ann and Ko, 1992) 
alongside sensitive strains.
The last three compounds in group 2 are tromethamine, glycerol, 
and benzoic acid (Supplementary Table S3). Tromethamine is 
predicted to interact with the hypothetical protein SPRG_04175, 
which contains a biotin and thiamin synthesis associated domain. 
Glycerol is predicted to interact with a histidinol dehydrogenase 
(SPRG_01876) and it has been explored previously for its antibacterial 
activity (Saegeman et  al., 2008). Benzoic acid is a common food 
preservative used to prevent the growth of yeast and molds 
(Brown and Swinburne, 1971). It most likely acts by interacting 
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with the putative hydrolase SPRG_02663, a hypothetical Xaa-Pro 
dipeptidyl-peptidase with a C-terminal non-catalytic domain. This 
compound showed activity against various stages of fungal 
development (Amborabé et  al., 2002) and it has recently been 
reported to be  effective against S. parasitica (Tedesco et  al., 2019), 
but its mechanism of inhibition was not investigated in these studies.
In conclusion, most of the inhibitors from group  2 have 
been shown to be  effective against other microbial pathogens, 
which support the validity of our approach, but a large majority 
of these compounds have never been tested against Saprolegnia. 
Therefore, the next step of our work involved the use of in 
vitro assays in the presence of representative chemicals of the 
different classes from group 2 to determine whether these selected 
inhibitors affect the growth of S. parasitica and to which extent.
Effect of Selected Compounds on the 
Growth of S. parasitica in Liquid Medium
From the above list of DrugBank compounds predicted to interact 
with single proteins of S. parasitica (group 2), nine representative 
compounds were tested for their growth inhibitory effect on 
Saprolegnia mycelium (Table  2; Supplementary Figure S1). In 
addition, copper sulfate, boric acid, and malachite green were 
used as positive controls, and the solvents of the different 
inhibitors were tested as negative controls (see Materials and 
Methods section). The solvents used for the preparation of stock 
solutions of the selected compounds, i.e., water, dimethyl sulfoxide 
(DMSO), ethanol, and acetone, did not inhibit the growth of 
S. parasitica at concentrations up to 1% v/v (Supplementary 
Figures S1A,B). These results are in keeping with previous 
reports (Xue-Gang et al., 2013; Hoskonen et al., 2015). However, 
some growth inhibition was observed with DMSO and ethanol 
at concentrations higher than 2% v/v, while growth was not 
perturbed in acetone at concentrations as high as 10% v/v.
Triclosan and triclocarban are predicted to target the 
protein SPRG_20215. Triclosan was found to be very effective 
when tested in liquid Machlis medium, with an MIC100 
concentration of 4  μg/ml (Supplementary Figure S1C), and 
significant levels of inhibition still observed at a lower 
concentration of 2  μg/ml. Benzoic acid (targeting the 
hypothetical protein SPRG_02663) and acetohydroxamic acid 
(targeting the putative urease SPRG_06801) arrested growth 
completely at 600 and 800  μg/ml, respectively. In addition, 
significant growth inhibition was still observed at lower 
concentrations (Supplementary Figures S1D,E). Recently, 
another group also reported benzoic acid as an effective 
compound against S. parasitica (Tedesco et al., 2019). However, 
in our experimental conditions, the 100 μg/ml concentration 
tested by Tedesco et  al. (2019) had no visible effect on 
Saprolegnia growth (Supplementary Figure S1D). Other 
compounds such as the sulfonamide sulfamethoxazole (800 μg/
ml), chloramphenicol (800 μg/ml), and azelaic acid (800 μg/
ml) showed growth inhibition at less than 1,000  μg/ml 
(Supplementary Figures S1F,G,H). Furthermore, glycerol, 
albendazole, and thiabendazole did not show any significant 
inhibitory effect up to a concentration of 1,000  μg/ml 
(Supplementary Figures S1I,J,K). The compounds that 
significantly inhibited the growth of S. parasitica at 
concentrations lower than 1,000  μg/ml were considered 
effective, and their activity was further analyzed.
As expected and reported earlier, the positive controls, such 
as copper sulfate (400  μg/ml; Sun et  al., 2014), boric acid 
(400  μg/ml; Ali et  al., 2014), and malachite green (2  μg/ml; 
Martin, 1968; Supplementary Figures S1L,M,N) arrested the 
growth of mycelium in the liquid medium of Machlis. However, 
the use of sesame seeds to inoculate the culture medium leads 
to variable amounts and quality of mycelium per cell culture 
well (Stueland et  al., 2005). This variability of inoculum size 
and quality is most likely responsible for the discrepancies 
reported in the literature with regard to the most efficient 
inhibitory concentrations of the different drugs.
Effect of the Selected Compounds on 
Radial Growth of S. parasitica on Solid 
Medium
To further evaluate the effect of the selected drugs on the 
growth of S. parasitica on a solid medium, we  prepared PDA 
plates supplemented with the minimum inhibitory concentrations 
of each drug determined in the in vitro assays in liquid Machlis 
medium (Table  2). As no growth was observed for any of 
the compounds tested, a lower (sub-inhibitory) concentration 
was used to test the effect of each inhibitor (Table 2; Figure 2; 
Supplementary Figure S2). As expected, normal growth was 
observed on PDA plates devoid of inhibitor. Similar to the 
observations in liquid medium (Supplementary Figure S1), 
no inhibition was observed in the presence of glycerol, 
albendazole, and thiabendazole (1,000  μg/ml each) after 72  h 
culture at 24°C (Supplementary Figures S2K,L,M). Significant 
levels of inhibition were observed in the presence of triclosan 
(4  μg/ml), benzoic acid (400  μg/ml), acetohydroxamic acid 
(600  μg/ml), sulfamethoxazole (800  μg/ml), azelaic acid 
(1,000  μg/ml), chloramphenicol (800  μg/ml), copper sulfate 
(400  μg/ml), boric acid (400  μg/ml), and malachite green 
(0.8  μg/ml; Figure  2; Supplementary Figure S2). 
Effect of the Selected Compounds on the 
Morphology of S. parasitica
Optical microscopy observations were made to analyze the 
effect of the selected inhibitors on the morphology of S. parasitica 
(Figure  3). In the absence of inhibitor, the hyphae appeared 
as translucent elongated cells. As opposed to the control, 
hyper-branching was commonly observed in the presence of 
some of the drugs that arrest the growth of the mycelium 
(Figure 3). The level of hyper-branching varied for the different 
compounds and was dose-dependent (Supplementary Figure S3). 
Pronounced hyper-branching was observed in the presence of 
triclosan (4  μg/ml), followed by benzoic acid (400  μg/ml), 
sulfamethoxazole (400  μg/ml), and boric acid (400  μg/ml). In 
the presence of acetohydroxamic acid, chloramphenicol, azelaic 
acid, and copper sulfate, low levels of side branching were 
visible (Figure  3). Interestingly, compared to other strong 
inhibitors of growth, no pronounced hyper-branching was 
visible in the presence of malachite green (Figure  3J). 
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Hyper-branching of the mycelium of S. parasitica in the presence 
of various inhibitors has not been explored previously. Therefore, 
an in-depth study of the mechanisms underlying the formation 
of such branching structures would be necessary to understand 
the effect of the inhibitors on cell development.
Homology Modeling and Docking
In this work, homology modeling and in silico docking studies 
were performed to better understand the mode of interaction 
between proteins and inhibitors. To this end, we  used the six 
compounds shown to be  effective in the in vitro assays along 
with their respective predicted target proteins (Figure  4; 
Supplementary Table S4). The six target proteins were 
SPRG_20215, SPRG_02663, SPRG_06801, SPRG_19504, 
SPRG_35021, and SPRG_13682. The 3D template structure for 
each of the selected proteins and corresponding percent sequence 
identity are presented in Supplementary Table S4. All proteins 
had a significantly high sequence identity of >30%, which 
allowed the generation of a reliable 3D protein structure, except 
for SPRG_02663, which has a slightly lower sequence identity 
(25.5%) with its template protein. The docking results show 
an approximate binding pattern of the inhibitors with their 
target proteins. Analysis of the docked complexes (compounds 
with their respective proteins) showed a considerable number 
of hydrogen bonding within the protein cavity or the active 
sites, which supports the specificity of the binding of each 
inhibitor with its respective protein. Furthermore, all the 
compounds showed significantly high binding energy toward 
their target, ranging from −7.7 to −4.4  kcal  mol−1, which 
indicates strong interactions between the ligands and their 
targets (Figure  4; Supplementary Table S4).
The results of the virtual screening were visualized using 
LigPlot to show the details of the interactions of the proteins 
with their respective ligands (Figure  4). Triclosan (DB08604), 
which is predicted to bind to the uncharacterized protein 
SPRG_20215, interacts through a single H bond between the 
O5 atom of the drug and the backbone amino group of Leu23. 
In addition, there are 13 residues from the protein that contribute 
to hydrophobic interactions. Similar interacting residues have 
been reported earlier for an enoyl-acyl carrier protein reductase 
from Thermus thermophilus (Otero et  al., 2012). The binding 
of benzoic acid (DB03793) to SPRG_02663 involves essentially 
hydrophobic interactions and a single H bond only. The 
SPRG_19504 protein complex with sulfamethoxazole (DB01015) 
involves seven amino acid residues from the protein that 
interact with the inhibitor through hydrophobic bonds while 
four residues are involved in H bonds. The interaction between 
SPRG_13682 and azelaic acid (DB00548) shows that the inhibitor 
interacts within the core hydrophobic pocket of the protein, 
with six hydrophobic residues involved in addition to the four 
H bonds associated with two polar and one negatively charged 
residues of the protein. Chloramphenicol (DB00446) interacts 
with SPRG_35021 through four H bonds while three other 
residues from the protein are engaged in hydrophobic interactions. 
The smallest inhibitor analyzed, acetohydroxamic acid (DB00551), 
forms H bonds with charged residues like His, Asp, and Lys, 
and it also interacts through hydrophobic bonds with five 
surrounding residues of the putative urease protein SPRG_06801. 
In summary, the docking study reveals that all complexes 
analyzed involve H bonding and hydrophobic interactions; it 
supports the initial screening results and provides initial evidence 
for the likely mechanisms of action of the six drug-proteins 
pairs identified in this work.
We have identified several compounds along with their probable 
target proteins using a subtractive proteomics approach and 
tested nine of these molecules in vitro for their efficacy against 
the growth of S. parasitica’s mycelium. Molecular docking studies 
FIGURE 3 | Optical microscopy observation of the effect of selected 
compounds on the growth of hyphae of S. parasitica after 24 h culture at 
24°C in Machlis medium. (A) No Drug, (B) Triclosan (4 μg/ml), (C) Benzoic 
acid (400 μg/ml), (D) Acetohydroxamic acid (600 μg/ml), (E) Sulfamethoxazole 
(400 μg/ml), (F) Chloramphenicol (800 μg/ml), (G) Azelaic acid (800 μg/ml), 
(H) Copper sulfate (200 μg/ml), (I) Boric acid (400 μg/ml), and (J) Malachite 
green (0.8 μg/ml). Scale bars = 100 μm.
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showed that these compounds exhibit minimum binding 
energies to their respective targets and present a strong 
affinity toward the active pockets of the proteins, which 
further supports the experimentally observed growth inhibition. 
Considering both the low effective concentration of some 
of these compounds against Saprolegnia and the fact that 
they are already used in humans suggest that they would 
be  safe to use in aquaculture. Moreover, the concentration 
of triclosan effective against Saprolegnia under our in vitro 
conditions (4 μg/ml) is significantly lower to its “no-observed-
adverse-effect level” (NOAEL) in humans (0.3% w/w; Lee 
et al., 2019). Similarly, acetohydroxamic acid, which is effective 
against S. parasitica at around 600–800  μg/ml, is used at up 
to 15 mg/kg/day for the treatment of human urinary infections 
and stones (Griffith et al., 1981; Williams et al., 1984). Azelaic 
acid (600–800  μg/ml against S. parasitica) has not shown 
any toxic effect during oral (≤20  g/day) or topical (20% 
cream) administration to humans (Fitton and Goa, 1991). 
Both sulfamethoxazole and chloramphenicol have been widely 
used as antibacterial agents in humans and animals. 
Sulfamethoxazole (800  μg/ml against S. parasitica) has been 
used in combination with trimethoprim for over 30  years, 
with a recommended dosage of up to 40 mg/kg/12 h (Dudley 
et  al., 1984). Similarly, also effective at 800  μg/ml against 
S. parasitica, chloramphenicol has a recommended dosage 
of 25  mg/kg/6  h (Powell and Nahata, 1982). Future work 
is required to confirm the probable mechanism of action 
of these promising compounds as well as their efficacy on 
the different developmental stages of S. parasitica (Srivastava 
et  al., 2018). It may also become possible to increase their 
efficacy by downstream modification and make them usable 
for the treatment of saprolegniasis in fish eggs, juvenile, 
and adult fish. Furthermore, the current integrative approach 
is not limited to saprolegniasis but it can also be  employed 




FIGURE 4 | Homology modeling and docking of the tested compounds with their respective target proteins. For each of the protein-ligand complexes, the LigPlot 
cartoons show the interactions between each inhibitor and the amino acid residues in the active site cleft of the respective proteins. (A) SPRG_20215 with triclosan 
(DB08604; binding energy −7.5 kcal/mol), (B) SPRG_02663 with benzoic acid (DB03793; binding energy −5.7 kcal/mol), (C) SPRG_06801 (putative urease) with 
acetohydroxamic acid (DB00551; binding energy −4.4 kcal/mol), (D) SPRG_19504 with sulfamethoxazole (DB01015; binding energy −4 kcal/mol),  
(E) SPRG_35021 with chloramphenicol (DB00446; binding energy −7.7 kcal/mol), and (F) SPRG_13682 with azelaic acid (DB00548; binding energy −5.0 kcal/mol).
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